Form 4 holding
CHIEF SCIENTIFIC OFF,SVP-R&D
Cara Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 167,247
- Estimated value
- $91,986
- Report date
- 01 Feb 2024
- Price
- $0.5500
- Ownership
- Direct
Frederique Ph.D. Menzaghi
Insider Reports History
- Location
- Shelton, CT
- Owner filing signature
- /s/ Darren DeStefano, Attorney-in-Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
SEC source record
1 source field
Source evidence
1 source field
Reported holdings for Frederique Ph.D. Menzaghi
Insider Reports Filed by Frederique Ph.D. Menzaghi
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 01 Feb 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 05 Feb 2024, 16:28
- Role
- CHIEF SCIENTIFIC OFF,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 23 Jun 2023
- Transactions
- 1
- Transaction value
- -$10,505
- Accepted by SEC
- 27 Jun 2023, 16:08
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 04 Apr 2023
- Transactions
- 1
- Transaction value
- -$13,419
- Accepted by SEC
- 06 Apr 2023, 17:12
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 03 Mar 2023
- Transactions
- 1
- Transaction value
- -$66,047
- Accepted by SEC
- 07 Mar 2023, 15:46
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 01 Mar 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Mar 2023, 15:36
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 21 Dec 2022
- Transactions
- 1
- Transaction value
- -$39,513
- Accepted by SEC
- 23 Dec 2022, 15:54
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 01 Apr 2022
- Transactions
- 1
- Transaction value
- -$21,247
- Accepted by SEC
- 05 Apr 2022, 17:49
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 25 Feb 2022
- Transactions
- 3
- Transaction value
- -$21,753
- Accepted by SEC
- 01 Mar 2022, 15:16
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 17 Dec 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 21 Dec 2021, 16:32
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 30 Aug 2021
- Transactions
- 1
- Transaction value
- -$54,627
- Accepted by SEC
- 01 Sep 2021, 18:07
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details
4
TVRD
Cara Therapeutics, Inc.
- Report period
- 24 Aug 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 26 Aug 2021, 18:15
- Role
- Chief Scientific Off,SVP-R&D
- Next action
- Open filing details